Please assess the completion status of the following clinical trial:

Trial Title: Boiled Peanut Oral Immunotherapy

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Age 1-16 years~* History of immediate hypersensitivity reaction to peanut~* Evidence of IgE mediated peanut hypersensitivity within a 12 month period of study enrollment~* SPT with wheal/flare of at least 3 x 6 mm and/or Peanut specific IgE \>0.35 kU/L~Exclusion Criteria:~* History of life threatening peanut anaphylaxis~* Asthma requiring more than medium dose ICS~* Prior participation in oral immunotherapy, sublingual immunotherapy or epicutaneous immunotherapy~* Oat allergy~* Cardiovascular Disease~* Use of beta-blockers (oral), angiotensin converting enzyme inhibitors, angiotensin receptor blockers, or calcium channel blockers~* Use of steroid medications in the following manners:~* Daily oral steroid dosing for greater than 1 month during the past year~* Burst or steroid course in the past 3 month before inclusion~* Greater than 2 bursts oral steroid courses in the past year of at least 1 week duration~* Pregnancy or lactation~* Eosinophilic Gastrointestinal Disease~* History of food protein-induced enterocolitis~* History of developmental delay or speech delay that precludes age- appropriate communication, in the opinion of the investigator

- Gender: ALL
- Minimum Age: 1 Year
- Maximum Age: 16 Years
- Healthy Volunteers: f

Study Arms:
- Boiled Peanut Powder (Type: EXPERIMENTAL): Boiled Peanut Powder

Based on this trial design, predict the completion outcome and termination type (if applicable).